Results 1 -
10
of
174
for
pembrolizumab
- FDA has approved the immunotherapy drug pembrolizumab (Keytruda®) for use in some patients with advanced gastric (stomach) cancer that is PD-L1 positive.
- ... clinical trial show combining the immune checkpoint inhibitor pembrolizumab (Keytruda) with chemotherapy helped some patients with advanced ...
- Melanoma/Statistics and Research ... Melanoma ... Skin Cancer/Statistics and Research ... Skin Cancer ... National Cancer Institute ... From the National Institutes of Health ... Find ...
- Targeted Therapy - Immunotherapy Combinations Effective for Advanced Kidney Cancer
(National Cancer Institute)
Kidney Cancer/Statistics and Research ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... For patients with advanced kidney cancer, ... - Lung Cancer/Diagnosis and Tests ... Lung Cancer ... National Cancer Institute ... From the National Institutes of Health ... Non-small cell lung cancer (NSCLC) treatment options ...
- Lung Cancer/Treatments and Therapies ... Lung Cancer ... National Cancer Institute ... From the National Institutes of Health ... Non-small cell lung cancer (NSCLC) treatment ...
- Skin Cancer/Treatments and Therapies ... Skin Cancer ... National Cancer Institute ... From the National Institutes of Health ... This page lists cancer drugs approved by ...
- Lung Cancer/Start Here ... Lung Cancer ... National Cancer Institute ... From the National Institutes of Health ... Non-small cell lung cancer (NSCLC) treatment options include ...
- Bladder Cancer/Treatments and Therapies ... Bladder Cancer ... National Cancer Institute ... From the National Institutes of Health ... Learn how bladder cancer is treated, ...
- Kidney Cancer/Treatments and Therapies ... Kidney Cancer ... National Cancer Institute ... From the National Institutes of Health ... Renal cell cancer treatment options ...